MOH — authorised 10 October 2014
- Marketing authorisation holder: HELSINN HLTHCARE
- Status: likely_approved
MOH authorised Akynzeo on 10 October 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 10 October 2014.
HELSINN HLTHCARE holds the UAE marketing authorisation.